Opportunity
Federal Register #2026-14198
SEC Grants CME Exemption for Cash-Settled Security Futures Settlement Pricing
Buyer
Securities and Exchange Commission
Posted
July 15, 2026
Identifier
2026-14198
This notice details a regulatory exemption granted by the Securities and Exchange Commission (SEC) to the Chicago Mercantile Exchange Inc. (CME) regarding settlement pricing for certain cash-settled security futures. - Government Buyer: - Securities and Exchange Commission (SEC) - OEM/Vendor Mentioned: - Chicago Mercantile Exchange Inc. (CME) - Products/Services Requested: - No procurement of products or services; this is a regulatory exemption - Key Details: - CME is permitted to use the closing price, rather than the opening price, of the underlying security for final settlement of certain cash-settled security futures - Applies to individual securities meeting criteria such as minimum market capitalization, deliverable supply, and average daily value of transactions - Conditions include heightened listing standards, quarterly reviews, position limits, limited listing schedule, and requirements for CME to provide studies and data on product impact - No specific products, part numbers, or purchase quantities are listed - This is not a procurement or contract award notice, but a regulatory action
Description
This notice published by the Securities and Exchange Commission (SEC) grants conditional exemptive relief to the Chicago Mercantile Exchange Inc. (CME) from the opening price settlement requirements of Rule 6h-1(b) under the Exchange Act for certain cash-settled security futures. CME seeks to list and trade cash-settled security futures on individual securities that meet specific listing standards, including market capitalization, deliverable supply, and average daily value of transactions. The exemption allows final settlement prices of these futures to reflect the closing price of the underlying securities rather than the opening price. The order includes conditions such as heightened listing standards, a limited listing schedule, and requirements for CME to provide studies and data on the impact of these products.